Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor–positive salivary gland cancers
Head & Neck2014Vol. 38(5), pp. 724–731
Citations Over TimeTop 10% of 2014 papers
Laura D. Locati, Federica Perrone, Barbara Cortelazzi, Salvatore Lo Vullo, Paolo Bossi, Gian Paolo Dagrada, Pasquale Quattrone, Cristiana Bergamini, Paolo Potepan, Enrico Civelli, C. Fallai, Silvana Pilotti, Lisa Licitra
Abstract
We confirm the activity of androgen deprivation therapy in androgen receptor-expressing recurrent/metastatic salivary gland cancers. The hypothesis that an androgen receptor increased gene copy number may represent a possible mechanism of primary resistance should be further investigated.
Related Papers
- → Response-Surface Modeling of the Effect of 5alpha-Dihydrotestosterone and Androgen Receptor Levels on the Response to the Androgen Antagonist Vinclozolin(2002)26 cited
- → Homologous Androgen Receptor Up-Regulation in Osteoblastic Cells May Be Associated with Enhanced Functional Androgen Responsiveness*(1999)33 cited
- → Androgen receptor: role in the female lower vertebrate reproduction(2010)
- Advances in Effects of Androgen on Androgen Receptors(2001)
- → THE PHYSIOPATHOLOGICAL ROLES OF ANDROGENS IN MOTONEURONS(2020)